Mitigation of multi-organ delayed effects of acute radiation exposure (DEARE) with ACE-inhibitor lisinopril
Active Definitive Contract Awarded Last action
- Contract number
- 75N93023C00013
- Awardee
-
The Medical College Of Wisconsin, Inc. UEI E8VWJXMMUQ67
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,275,826
Award facts
- Opportunity
-
- Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices Pre-Solicitation · 75N93021R00019 · Posted Nov 15, 2021
- Contract value 100% obligated
- $3,275,826.00 Current and potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 16 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Wauwatosa, WI 53226, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $177,845 | |
| Exercise an Option | $999,637 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $998,346 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $100,000 | |
| Other Administrative Action | $0 | |
| Original award | $999,998 |
Show all 11
About this award
The National Institute of Allergy and Infectious Diseases awarded a $3.275 million definitive contract to The Medical College Of Wisconsin, Inc. for mitigation of multi-organ delayed effects of acute radiation exposure (DEARE) with ACE-inhibitor lisinopril on July 1, 2023, under cost-no-fee pricing with ultimate completion June 30, 2027.
The originating pre-solicitation (posted November 15, 2021) sought research and development of biodosimetry approaches and medical countermeasures to assess and mitigate acute or delayed radiation injuries, with proposals required to demonstrate efficacy of medical countermeasures when administered at least 24 hours post-exposure or effectiveness of biodosimetry signatures within timeframes ranging from 30 minutes to 7 days. Place of performance is Wauwatosa, Wisconsin.
Subcontractors include New York University School of Medicine (awarded September 11, 2025, June 30, 2025, and February 22, 2024) and Heska Corporation (awarded June 30, 2025).
Service Contract Inventory reporting shows actual government-invoiced labor of $96 thousand in FY2023 (1.0 FTE, 2,078 contractor hours), $820 thousand in FY2024 (3.5 FTEs, 7,271 contractor hours), and $1.7 million in FY2025 (5.2 FTEs). Derived government-paid hourly rates rose from $46.22/hr in FY2023 to $112.78/hr in FY2024. In FY2025, the prime self-performed all reported hours with no subcontractors invoiced.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| New York University | $57,795 | |
| Heska Corporation | $33,149 | |
| New York University | $56,288 | |
| New York University | $54,831 |
Quick answers
Who was awarded contract 75N93023C00013?
75N93023C00013 was awarded to The Medical College Of Wisconsin, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2023.
How much is contract 75N93023C00013 worth?
The government has obligated $3,275,826 on 75N93023C00013.
Was contract 75N93023C00013 competed?
The extent of competition for 75N93023C00013 was full and open competition. The government received 16 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award